Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 4/20 | 0.49 |
| ▸ | CREBBP | Q92793 | 4/20 | 0.49 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | DPYD | Q12882 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4596693 | 0.82 | CREBBP (0.62) | BRD4CREBBPNFE2L2TRPA1MAOA | |
| SCHEMBL4228696 | 0.78 | BRD4 (0.43) | BRD4CREBBPNFE2L2TRPA1DHFR | |
| SCHEMBL4228692 | 0.78 | BRD4 (0.43) | BRD4CREBBPNFE2L2TRPA1DHFR | |
| SCHEMBL6047933 | 0.70 | NFE2L2 (0.42) | BRD4CREBBPNFE2L2TRPA1DHFR | |
| SCHEMBL4596028 | 0.68 | PARP1 (0.33) | — | |
| SCHEMBL4596860 | 0.68 | PARP1 (0.36) | — | |
| SCHEMBL11091102 | 0.68 | SMN1; SMN2 (0.35) | BRD4CREBBPMAOAMAOB | |
| SCHEMBL11667493 | 0.66 | NFE2L2 (0.48) | BRD4CREBBPNFE2L2TRPA1DHFR | |
| SCHEMBL31092531 | 0.66 | NFE2L2 (0.48) | BRD4CREBBPNFE2L2TRPA1DHFR | |
| SCHEMBL4649843 | 0.66 | HTR1A (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1874750-A1 | DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS | Wyeth Incoporated (US) | 2008-01-09 | — | — | EP | disclosed |